New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2012
12:58 EDTNOK, RIMM, RATE, ASNA, CHRS, MCHP, SMSC, CHK, OPEN, RRD, AGN, AGP, TRIP, CVS, CBS, TWX, CMCSAOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday, following disappointing jobs data at home and abroad. The market began the session in the red following worse than expected data from the ADP employment change report. The market hit its lows shortly after the open and has moved in narrow range since, but has trended higher in the last hour. The move higher came after a slightly better than expected factory orders report and an energy inventories report that showed a larger draw down of gas and distillate supplies than were forecast... ECONOMIC EVENTS: In the U.S., ADP said that 119,000 private-sector jobs were added in April, missing expectations for 170,000 job additions. Factory orders declined 1.5% in March, versus expectations of a 1.6% drop. In Europe, two pieces of disappointing data were reported: unemployment rose to 10.9% in the shared-currency bloc, its highest level since the euro's launch in 1999, and the eurozone's manufacturing sector contracted at the sharpest pace in almost three years, with the manufacturing PMI for the region falling to 45.9 in April from 47.7 in March. In China, HSBC's "flash" PMI manufacturing survey improved to 49.3 from 48.3 in the prior reading... COMPANY NEWS: A number of media companies reported better than expected results on both the top and bottom lines, including Comcast (CMCSA), Time Warner (TWX) and CBS (CBS), but only CBS saw its shares move up following its announcement. CBS shares gained more than 3%, while Comcast fell 1.5% and Time Warned moved almost 2% lower... Among other companies reporting earnings, advancers included CVS Caremark (CVS), TripAdvisor (TRIP) and Amerigroup (AGP); decliners included Allergan (AGN), R.R. Donnelley (RRD) and OpenTable (OPEN)... Chesapeake (CHK) gave up all of the 8% in gains it realized yesterday and then some, falling about 13% after its earnings missed consensus and Reuters reported on new potential conflicts of interests for its CEO Aubrey McClendon... MAJOR MOVERS: Among the notable gainers were Standard Microsystems (SMSC), up 38%, on news it will be acquired by Microchip Technology (MCHP) for $37 per share in cash, and both Charming Shoppes (CHRS), up over 23%, and Ascena Retail Group (ASNA), up almost 11%, after the companies announced plans for Ascena to acquire Charming. Noteworthy losers included Bankrate (RATE), down 12%, following its earnings report, and Research in Motion (RIMM), down almost 5%, as investors continue to react negatively to the company's new product announcements and Nokia (NOK) sued RIM and others in the U.S. and Germany on accusations of patent infringement... INDICES: Near noon, the Dow was down 47.38, or 0.36%, to 13,231.94; the Nasdaq was down 1.63, or 0.05%, to 3,048.81; and the S&P 500 was down 6.69, or 0.48%, to 1,399.13.
News For CMCSA;TWX;CBS;CVS;TRIP;AGP;AGN;RRD;OPEN;CHK;SMSC;MCHP;CHRS;ASNA;RATE;RIMM;NOK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
October 7, 2014
17:49 EDTAGNValeant up 3.9% after Dow Jones says planning to boost Allergan bid
Subscribe for More Information
17:47 EDTAGNValeant, Pershing Square planning to boost Allergan bid by $15 a share, DJ says
Subscribe for More Information
15:21 EDTAGNAllergan warms to sale as Actavis plans new approach, Reuters says
Subscribe for More Information
15:01 EDTAGNAllergan up 1.5% following report on Actavis planned approach on merger
14:59 EDTAGNActavis plans new approach to Allergan, Reuters reports
Subscribe for More Information
10:52 EDTNOKNokia suspends handset production at Chennai facility, Reuters reports
Subscribe for More Information
10:02 EDTTWXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:05 EDTCBSCBS risk/reward attractive at current levels, says FBR Capital
FBR Capital believes weaker September quarter TV trends and downward estimate revisions have pushed CBS shares into "value territory." The firm views the current risk/reward on shares as attractive and keeps an Outperform rating on CBS with a reduced price target of $71.
07:49 EDTTWXTime Warner initiated with a Buy at MKM Partners
Target $90.
07:48 EDTAGNSalix reinstated with a Buy at Jefferies
Subscribe for More Information
07:12 EDTAGNAllergan requests Ackman be hindered from voting at meeting, Bloomberg says
In an effort to avoid an unsolicited $54B acquisition offer from Valeant Pharmaceuticals (VRX), Allergan (AGN) filed a request in a California court for a judge to hinder Bill Ackmanís Pershing Square from voting its 10% stake at the December shareholder meeting, according to Bloomberg, citing the filing. A hearing regarding Allergan's request is set to occur on October 28. Reference Link
October 6, 2014
18:15 EDTTWXTime Warner unit announces 10% reduction of global workforce
Subscribe for More Information
13:21 EDTASNAPRIMECAP reports 4.98% passive stake in Ascena Retail
Subscribe for More Information
11:15 EDTAGNDurata surges after Actavis takeover
Shares of Durata Therapeutics (DRTX) are surging after the drugmaker agreed to be acquired by its larger industry peer, Actavis (ACT). WHAT'S NEW: Actavis announced it will commence a tender offer to acquire all of the outstanding shares of Durata common stock for $23.00 per share in cash, or approximately $675M in the aggregate, and contingent value rights entitling the holder to receive additional cash payments of up to $5.00 per share if certain regulatory or commercial milestones related to Durata's lead product Dalvance are achieved. If Dalvance is approved in Europe for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI, holders of the CVR will receive $1.00 per share. If Dalvance is approved for single dose administration by the FDA, holders of the CVR will receive $1.00 per share. If a net global Dalvance revenue threshold is met over a designated time period, holders of the CVR will receive $3.00 per share. Actavis expects the acquisition to be accretive by the end of the first year, it stated. WHAT'S NOTABLE: The acquisition comes after Durata Therapeutics was granted a Special Protocol Agreement by the FDA for its Phase 3 study of Dalvance on October 3. The study was designed to study Dalvance for the treatment of patients with community-acquired pneumonia and pediatric osteomyelitis. ANALYST REACTION: BMO Capital views the acquisition as a "good deal" for Actavis that is in line with CEO Brent Saunders' goal of making investments that complement its existing business. BMO believes the acquisition does not extend Actavis' balance sheet too far, and therefore does not prevent the company from doing additional deals. The firm expects there could be more deal-related news ahead for Actavis. The Fly notes Bloomberg reported on October 2 that Salix Pharmaceuticals (SLXP) was discussing selling itself to Actavis after failing to reach a deal with Allergan (AGN). PRICE ACTION: During morning trading, Durata Therapeutics gained $9.93, or 71.5%, to $23.81, Actavis slipped $1.95, or 0.8% to $244.12, and Salix fell $4.02, or 2.6%, to $148.85.
11:09 EDTMCHPOptions with increasing implied volatility
Subscribe for More Information
10:16 EDTTWXNBA confirms new nine-year deal with Turner Broadcasting, Disney
Subscribe for More Information
08:07 EDTAGNSalix slips in pre-market trade after Actavis strikes deal for Durata
Note that Bloomberg reported on October 2, citing people with knowledge of the matter, that Salix Pharmaceuticals (SLXP) was discussing selling itself to Actavis (ACT) after failing to reach a deal with Allergan (AGN). Actavis announced this morning that it has reached a deal to acquire Durata Therapeutics (DRTX) for $675M, or $23.00 per share. In pre-market trading, shares of Salix are down nearly 2% to $150 per share.
07:01 EDTAGNAllergan Q3 results likely to beat expectations, says Bernstein
Bernstein predicts that Allergan's Q3 EPS will exceed expectations by 15c, driven by cost cutting.
06:41 EDTTWX, CMCSA'Gone Girl' leads weekend box office with $38M in sales, WSJ reports
Subscribe for More Information
06:40 EDTTRIPTripAdvisor Instant Book available at 58% of top hotels, says Deutsche Bank
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use